Arcuate Nucleus Neurons

Introduction

flowchart TD
    cell_types_arcuate_nucleus_neu["Arcuate Nucleus Neurons"]
    cell_types_arcuate_nucleus_neu["Introduction"]
    cell_types_arcuate_nucleus_neu -->|"related to"| cell_types_arcuate_nucleus_neu
    style cell_types_arcuate_nucleus_neu fill:#81c784,stroke:#333,color:#000
    cell_types_arcuate_nucleus_neu["infobox-cell"]
    cell_types_arcuate_nucleus_neu -->|"related to"| cell_types_arcuate_nucleus_neu
    style cell_types_arcuate_nucleus_neu fill:#81c784,stroke:#333,color:#000
    cell_types_arcuate_nucleus_neu["infobox-header"]
    cell_types_arcuate_nucleus_neu -->|"related to"| cell_types_arcuate_nucleus_neu
    style cell_types_arcuate_nucleus_neu fill:#81c784,stroke:#333,color:#000
    cell_types_arcuate_nucleus_neu["label"]
    cell_types_arcuate_nucleus_neu -->|"related to"| cell_types_arcuate_nucleus_neu
    style cell_types_arcuate_nucleus_neu fill:#81c784,stroke:#333,color:#000
    style cell_types_arcuate_nucleus_neu fill:#4fc3f7,stroke:#333,color:#000

The arcuate nucleus (ARC) is a critical hypothalamic region that plays a vital role in integrating metabolic signals and controlling energy homeostasis, growth, and reproduction

The arcuate nucleus has emerged as an important focus in neurodegenerative disease research due to its roles in metabolic regulation, neuroendocrine function, and its connections to brain regions affected in Alzheimer’s and Parkinson’s diseases

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

• Cell Ontology (CL:1001135)

• OBO Foundry (CL:1001135)

• Allen Brain Cell Atlas

• CellxGene Census

• Human Cell Atlas

Neuronal Populations

POMC Neurons

Proopiomelanocortin (POMC) neurons in the ARC produce alpha-melanocyte-stimulating hormone (α-MSH) and cocaine- and amphetamine-regulated transcript (CART), which promote satiety and energy expenditure^{1Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin1999 · PMID 10470076Open reference}. These neurons are essential for maintaining energy homeostasis and have been implicated in neurodegenerative processes due to their metabolic regulatory functions.

NPY/AgRP Neurons

Neuropeptide Y (NPY) and agouti-related peptide (AgRP) neurons represent the primary orexigenic (appetite-stimulating) population in the ARC^{2Rapid versus delayed stimulation of feeding by the same Arch/NPY neurons2013 · PMID 23467346Open reference}. These neurons co-release GABA and are activated during fasting to stimulate food intake. Dysregulation of NPY/AgRP signaling has been associated with metabolic disturbances in neurodegenerative diseases^{3NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates2005 · PMID 16254186Open reference}.

Dopamine Neurons

The ARC contains tyrosine hydroxylase (TH)-positive dopamine neurons that project to various brain regions^{4Dopamine in the hypothalamus: facts and implications2020 · PMID 32089173Open reference}. These neurons are part of the tuberoinfundibular dopamine (TID) pathway and regulate prolactin secretion. Alterations in ARC dopamine function have been implicated in Parkinson’s disease pathophysiology^{5Dopamine neuron systems in the brain: emerging functional properties2007 · PMID 17882254Open reference}.

Role in Energy Homeostasis

The ARC serves as the brain’s primary metabolic sensor, integrating signals from:

Hormonal Inputs:

• Leptin from adipocytes

• Insulin from the pancreas

• Ghrelin from the stomach

Nutrient Signals:

• Glucose

• Fatty acids

• Amino acids

These signals are processed by ARC neurons to modulate feeding behavior, energy expenditure, and hormone secretion^{6Central nervous system control of food intake and body weight2006 · PMID 17013235Open reference}.

Connections to Neurodegeneration

Alzheimer’s Disease

The hypothalamus, including the ARC, shows early pathology in Alzheimer’s disease. Key connections include:

• Metabolic dysfunction and insulin resistance in AD

• Disrupted leptin and ghrelin signaling

• Early hypothalamic atrophy detected in AD patients

• Links between metabolic syndrome and AD risk^{7Alzheimer's disease is type 3 diabetes-evidence reviewed2008 · PMID 19083414Open reference}

Parkinson’s Disease

The ARC is affected in PD through:

• Autonomic dysfunction involving hypothalamic nuclei

• Metabolic disturbances common in PD patients

• Connections to brainstem regions affected by alpha-synuclein pathology

• Potential role in PD-related weight loss and cachexia^{8Non-motor symptoms of Parkinson's disease: diagnosis and management2006 · PMID 16488379Open reference}

Hypothalamic-Pituitary Axis

The ARC is central to the hypothalamic-pituitary axis, regulating:

Anterior Pituitary:

• Growth hormone (GH)

• Thyroid-stimulating hormone (TSH)

• Adrenocorticotropic hormone (ACTH)

• Prolactin

• Gonadotropins (LH, FSH)

Posterior Pituitary:

• Oxytocin

• Vasopressin

These neuroendocrine connections explain how hypothalamic dysfunction can affect systemic physiology and potentially influence neurodegenerative processes^{9Neurohypophyseal hormones in brain2020 · PMID 33098890Open reference}.

Clinical Significance

Metabolic Disorders

ARC dysfunction contributes to:

• Obesity

• Type 2 diabetes

• Metabolic syndrome

These conditions are recognized risk factors for neurodegenerative diseases, establishing the ARC as a potential therapeutic target^{10Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and glucose disorders2010 · PMID 19303917Open reference}.

Therapeutic Implications

Modulating ARC neuronal activity represents a potential approach for:

• Metabolic intervention in neurodegeneration

• Neuroprotective strategies targeting hypothalamic function

• Addresses the growing evidence linking metabolic health to brain aging

• Alzheimer’s Disease

• Parkinson’s Disease

External Links

• PubMed

• KEGG Pathways